Working while unwell: Workplace impairment in people with severe asthma
暂无分享,去创建一个
P. Gibson | C. Jenkins | M. Hew | F. Thien | P. Reynolds | S. Hiles | P. Gibson | J. Upham | P. Bardin | V. McDonald | P. Wark | D. Langton | C. Katelaris | H. Reddel | M. Baraket | L. Jayaram | J. Garrett | J. Bowden | A. Southcott | V. Kritikos | M. Peters | E. Harvey | L. Chung | G. Katsoulotos | E. Yap | M. Koh | B. Cochrane | P. Middleton | B. Brockway | J. Rimmer | N. Radhakrishna | B. Brockway | G. Marks | M. Sutherland | G. Katsoulotos | I. Yang | A. Nanguzgambo | D. Langton | G. Foxley | M. Peters | E. S. Harvey | Z. Bhikoo | M. Lambert | A. Lara Rivero | C. Jenkins | P. Gibson | Gloria J Foxley | Marina Lambert | A. Rivero | Peter G. Middleton
[1] V. McDonald,et al. “I have lost in every facet of my life”: the hidden burden of severe asthma , 2017, European Respiratory Journal.
[2] M. Hew,et al. A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes. , 2017, The journal of allergy and clinical immunology. In practice.
[3] G. Wang,et al. Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network. , 2017, Journal of thoracic disease.
[4] S. Srivastava,et al. Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety. , 2017, Respiratory medicine.
[5] C. Nygård,et al. An effort to assess the relation between productivity loss costs and presenteeism at work , 2017, International journal of occupational safety and ergonomics : JOSE.
[6] Anand A. Dalal,et al. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study. , 2017, The journal of allergy and clinical immunology. In practice.
[7] M. Dibonaventura,et al. Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys , 2016, International journal of chronic obstructive pulmonary disease.
[8] D. Price,et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry , 2016, Thorax.
[9] T. Seemungal,et al. Reality and understanding of asthma control , 2015, Chronic respiratory disease.
[10] M. Schatz,et al. Changes in asthma control, work productivity, and impairment with omalizumab: 5-year EXCELS study results. , 2015, Allergy and asthma proceedings.
[11] M. Sadatsafavi,et al. Interaction effect of psychological distress and asthma control on productivity loss? , 2015, European Respiratory Journal.
[12] O. Vandenplas,et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). , 2014, Respiratory medicine.
[13] N. Thomson,et al. The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry , 2014, Thorax.
[14] James O. Prochaska,et al. Examining Relationships between Multiple Health Risk Behaviors, Well-Being, and Productivity , 2014, Psychological reports.
[15] D. Globe,et al. The relationship between asthma, asthma control and economic outcomes in the United States , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.
[16] L. Lynd,et al. The preventable burden of productivity loss due to suboptimal asthma control: a population-based study. , 2014, Chest.
[17] J. Vietri,et al. Poor Asthma Control Among US Workers: Health-Related Quality of Life, Work Impairment, and Health Care Use , 2014, Journal of occupational and environmental medicine.
[18] R. Glasgow,et al. Does Severity of Depression Predict Magnitude of Productivity Loss , 2014 .
[19] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[20] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[21] R. Rufino,et al. Asthma and the socio-economic reality in Brazil , 2013, The World Allergy Organization journal.
[22] P. Ojeda,et al. Costs associated with workdays lost and utilization of health care resources because of asthma in daily clinical practice in Spain. , 2013, Journal of investigational allergology & clinical immunology.
[23] A. Zbrozek,et al. The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.
[24] D. Edington,et al. The Cost and Impact of Health Conditions on Presenteeism to Employers , 2012, PharmacoEconomics.
[25] R. Luukkonen,et al. Reduced work ability in middle-aged men with asthma from youth--a 20-year follow-up. , 2011, Respiratory medicine.
[26] F. Caamaño-Isorna,et al. Factors Associated with a Higher Prevalence of Work Disability among Asthmatic Patients , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.
[27] C. Brightling,et al. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry , 2010, Thorax.
[28] S. Sullivan,et al. Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[29] Gary Johns,et al. Presenteeism in the workplace: A review and research agenda. , 2010 .
[30] B. Dean,et al. The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.
[31] S. Bolge,et al. The Association Between Asthma Control and Health Care Utilization, Work Productivity Loss and Health-Related Quality of Life , 2009, Journal of occupational and environmental medicine.
[32] G. Aronsson,et al. Sickness Presenteeism Today, Sickness Absenteeism Tomorrow? A Prospective Study on Sickness Presenteeism and Future Sickness Absenteeism , 2009, Journal of occupational and environmental medicine.
[33] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[34] M. Schatz,et al. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes. , 2009, Mayo Clinic proceedings.
[35] E. Bleecker,et al. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[36] S. Peters,et al. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. , 2007, The Journal of allergy and clinical immunology.
[37] D. Curran‐Everett,et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.
[38] P. A. Russo,et al. Extent, patterns, and burden of uncontrolled disease in severe or difficult‐to‐treat asthma , 2007, Allergy.
[39] C. Iribarren,et al. Risk factors for work disability in severe adult asthma. , 2006, The American journal of medicine.
[40] H. Birnbaum,et al. Healthcare and Workloss Costs Associated With Patients With Persistent Asthma in a Privately Insured Population , 2006, Journal of occupational and environmental medicine.
[41] L. Trupin,et al. Work life of persons with asthma, rhinitis, and COPD: A study using a national, population-based sample , 2006, Journal of occupational medicine and toxicology.
[42] S. Holgate,et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[43] Klas Svensson,et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.
[44] Philip Marcus,et al. Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.
[45] M. Charlson,et al. Adverse work outcomes and events attributed to asthma. , 2003, American journal of industrial medicine.
[46] McClellan Ve,et al. Asthma and the employment experience. , 1990 .
[47] V. McClellan,et al. Asthma and the employment experience. , 1990, The New Zealand medical journal.